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Abstract 
Review on MIR107, with data on DNA/RNA and 
where the gene is implicated. 
Identity 
Other names: MIRN107, miR-107 
HGNC (Hugo): MIR107 
Location: 10q23.31 
DNA/RNA 
Description 
miR-107 is located on the 10th chromosome. miR-
107 gene is of 87 bp and starts from 91352500 bp 
from pter and ends at 91352586 bp from pter on 
minus strand. Total number of exon present is one 
and coding exon is 0. 
miR-107 paralogs include miR-103(1), miR103(2)  
and miR107 which reside in three homologous 
PANK genes - PANK3, PANK2 and PANK1 
respectively. miR-103 is in a PANK gene intron but 
miR-107 is located intergenically (Finnerty et al., 
2010). 
Transcription 
hsa-miR-107 is a product of gene 
ENSG00000198997 and has 1 transcript 
ENST00000362127 of 87 bp. Precursor miRNA 
transcribed by this gene is of 81 base pairs 
(location: complement (91352504..91352584) on 
DNA and 1:81 on RNA) while mature miRNA is of 
23 bp transcribed from sequence located at 
(91352513..91352535)bp on minus strand of DNA 
and 50:72 bp on RNA. Transcript is intron-less. 
Pseudogene 
Paralogs: hsa-miR-107 has two paralogs: 
1) hsa-miR-103-1 HGNC: 31490 
2) hsa-miR-103-2 HGNC: 31491 
 
Figure 1.  
 
Table 1. Overlapping transcripts. 
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Protein 
Note 
No protein product. 
Mutations 
Note 
SNP 
1) rs377494950 
GCAACACTGTAAAGAAGCTGAAAGCA[A/G]
GAGAATATCGAATATTGCAAGTCGA 
AllelePos=51; totalLen=101; snpclass=1; 
alleles='A/G'. (NCBI dbSNP) 
2) rs199975460 
CCCTGTACAATGCTGCTTGAACTCCA[C/T]G
CCACAAGGCAACACTGTAAAGAAG 
AllelePos=101; totalLen=201; snpclass=1; 
alleles='C/T'. (NCBI dbSNP) 
- SNP Loc relative to pre-miR 40 
- Primary miRNA Eenergy: -29.6 kcal/mol 
- SNP-miRNA Eenergy: -30.3kcal/mol 
- ∆∆G: -0.7kcal/mol (microRNA-related Single 
Nucleotide Polymorphims) 
For miRNA-107 NCBI Reference Sequence 
NR_029524.1 (Contig NT_030059.13) following 
56 SNPs have been reported in dbSNP (NCBI 
dbSNP). 
Implicated in 
Breast cancer 
Oncogenesis 
miR-107 was reported to be over expressed in 
malignant tissues from patients with advanced 
breast cancer, and its expression showed an inverse 
correlation with let-7 expression in tumors and in 
cancer cell lines Ectopic expression of miR-107 in 
human cancer cell lines led to destabilization of 
mature let-7, increased expression of let-7 targets, 
and increased malignant phenotypes (Chen et al., 
2011). 
Colon cancer 
Oncogenesis 
P53-induced miR-107 inhibited HIF-1 and tumor 
angiogenesis in colon cancer specimens. 
Furthermore, overexpression of miR-107 in tumor 
cells suppresses tumor angiogenesis, tumor growth, 
and tumor VEGF expression in mice (Yamakuchi et 
al., 2010). 
Colorectal cancer 
Oncogenesis 
miR-103/107 targeted the known metastasis 
suppressors death-associated protein kinase 
(DAPK) and Krüppel-like factor 4 (KLF4) in 
colorectal cancer cells, resulting in increased cell 
motility and cell-matrix adhesion and decreased 
cell-cell adhesion and epithelial marker expression. 
miR-103/107 expression was increased in the 
presence of hypoxia, thereby potentiating DAPK 
and KLF4 downregulation and hypoxia-induced 
motility and invasiveness (Chen et al., 2012). 
Esophageal cancer 
Oncogenesis 
Circulating and tissue miR-107 was found to be 
downregulated in esophageal cancer tissues and 
sera samples as compared to matched non-
malignant tissues and healthy controls respectively 
(Sharma et al., 2013). 
Gastric cancer 
Prognosis 
miR-107 expression in gastric cancer tissues was 
demonstrated as an independent prognostic factor 
for overall survival rates (OS) and disease-free 
survival rates (DFS). OS and DFS of patients with 
high miR-107 expression were significantly worse 
than those of patients with low miR-107 expression 
(Inoue et al., 2012). 
Oncogenesis 
Its ectopic expression reduced both mRNA and 
protein expression levels of CDK6, inhibited 
proliferation, blocked invasion of gastric cancer 
cells and also induced G1 cell cycle arrest (Feng et 
al., 2012). miR-107 expression showed significant 
association with depth of tumor invasion, lymph 
node metastasis and stage. Moreover, significant 
inverse correlation was found between miR-107 
and DICER1 mRNA (Inoue et al., 2012) and it was 
demonstrated that miR107 regulates tumor invasion 
and metastasis in gastric cancer by targeting 
DICER1 (Li et al., 2011). 
Glioma 
Oncogenesis 
miR-107 inhibited proliferation of Glioma cells 
(Chen et al., 2013a), downregulated expression of 
CDK6 and notch-2 and also inhibited glioma cell 
migration and invasion by modulating notch-2 
expression (Chen et al., 2013b). He et al., (2013) 
reported that upregulation of miR-107 suppressed 
glioma cell growth through directly targeting 
SALL4, leading to the activation of FADD/caspase-
8/caspase-3/caspase-7 signaling pathway of cell 
apoptosis. 
Head and neck squamous cell 
carcinoma 
Oncogenesis 
microRNA-107 functions as a candidate tumor-
suppressor gene in head and neck squamous cell 
carcinoma by downregulation of protein kinase Cε. 
Treatment with miR-107 significantly blocked cell 
proliferation, DNA replication, colony formation 
and invasion in head and neck squamous cell 
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carcinoma (HNSCC) cell lines (Datta et al., 2012). 
Moreover, Lipid-based nanoparticle delivery of 
Pre-miR-107 inhibits the tumorigenicity of HNSCC 
(Piao et al., 2012). 
B-cell chronic lymphocytic leukemia 
Oncogenesis 
Down-regulation of miRNA-107 due to epigenetic 
transcriptional silencing results in overexpression 
of its target gene PLAG1 (pleomorphic adenoma 
gene 1), a well known oncogenic transcription 
factor (Pallasch, 2009). 
Lung cancer 
Oncogenesis 
MiR-107 suppressed cell proliferation in human 
non-small cell lung cancer cell lines (Takahashi et 
al., 2009) and induced G1 cell cycle arrest. 
Neuroblastoma 
Oncogenesis 
miR-103 and miR-107 regulate CDK5R1 
expression and their overexpression, as well as 
CDK5R1 silencing, caused a reduction in migration 
ability of neuroblastoma cells (Moncini et al., 
2011). 
Pancreatic cancer 
Oncogenesis 
Lee et al. (2009) reported that epigenetic silencing 
of miR-107 regulates CDK6 expression in 
pancreatic cancer. 
Pituitary adenomas 
Oncogenesis 
miR-107 is overexpressed in Pituitary adenomas 
and may act as tumor suppressor. Pituitary tumor 
suppressor gene AIP (aryl hydrocarbon receptor-
interacting protein) is a miR-107 target and both 
may have roles in tumorigenesis (Trivellin et al., 
2012). Recent studies have demonstrated regulation 
of miR-107 by P53 tumor suppressor. 
Prostate cancer 
Oncogenesis 
Multiple members of the miR-107 gene group 
repress mitogen and growth factor granulin (GRN) 
protein levels when transfected into prostate cancer 
cells (Wang et al., 2010a). GRN is dysregulated via 
miR-15/107 gene group in multiple human cancers, 
which may provide a potential common therapeutic 
target. 
Various cancers 
Cytogenetics 
- Entrez Gene cytogenetic band: 10q23.31  
- Ensembl cytogenetic band: 10q23.31  
- HGNC cytogenetic band: 10q23.31 
- Type: Cytoband, Source: UCSC, Length: 
3300000, Stain: gpos75 (Database of Genomic 
Variants) 
Hypoxia and angiogenesis 
Note 
miR-107 mediates p53 regulation of hypoxic 
signaling and tumor angiogenesis in colon cancer. It 
regulates hypoxia signaling by suppressing 
expression of hypoxia inducible factor-1β (HIF-1β). 
Moreover, overexpression of miR-107 in tumor 
cells suppresses tumor angiogenesis, tumor growth 
and tumor VEGF expression in mice (Yamakuchi et 
al., 2010). 
Metabolism 
Note 
miR-107 has been implicated in metabolism of 
cellular lipids (Wilfred et al., 2007) and in 
regulation of insulin sensitivity. Caveolin-1, a 
critical regulator of insulin receptor has been 
identified as a direct target of miR-103/107 
(Trajkovski et al., 2011). Human CYP2C8, a 
member of CYP2C subfamily of cytochrome P450 
enzymes is also post-transcriptionally regulated by 
microRNAs 103 and 107 in human liver (Zhang et 
al., 2012). 
Alzheimer's 
Note 
Expression of miR-107 decreases early in 
Alzheimer's disease and may accelerate disease 
progression through regulation of beta-site amyloid 
precursor protein-cleaving enzyme 1 (Wang et al., 
2008). Moreover, miR-107 expression tended to 
correlate in a negative fashion with neuritic 
plaque(NPs) and neurofibrillary tangle (NFTs) 
(Nelson and Wang, 2010) microRNAs-107/miR-
103 represse translation of actin-binding protein 
cofilin, and their reduced levels are associated with 
elevated cofilin protein levels and formation of rod-
like structures in a transgenic mouse model of 
Alzheimer's disease (Yao et al., 2010). 
Brain injury and neurodegenerative 
disease 
Note 
miR-107 contributes to regulation of 
granulin/progranulin with implications for 
traumatic brain injury and neurodegenerative 
disease (Wang et al., 2010b). 
Schizophrenia 
Note 
Increased levels of miR-107 contribute to the 
marked loss of cortical CHRM1 in schizophrenia 
which may be a differentiating pathophysiology 
(Scarr et al., 2013). 
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Table 3. LOH and homozygous deletion on chromosome 10q (10q22-10q23) in primary hepatocellular carcinoma (Zhu et al., 
2004). See Supplementary Table S1. 
 
Breakpoints 
See Table 3. 
References 
Zhu GN, Zuo L, Zhou Q, Zhang SM, Zhu HQ, Gui SY, 
Wang Y. Loss of heterozygosity on chromosome 10q22-
10q23 and 22q11.2-22q12.1 and p53 gene in primary 
hepatocellular carcinoma. World J Gastroenterol. 2004 Jul 
1;10(13):1975-8 
Wilfred BR, Wang WX, Nelson PT. Energizing miRNA 
research: a review of the role of miRNAs in lipid 
metabolism, with a prediction that miR-103/107 regulates 
human metabolic pathways. Mol Genet Metab. 2007 
Jul;91(3):209-17 
Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, 
Huang Q, Rigoutsos I, Nelson PT. The expression of 
microRNA miR-107 decreases early in Alzheimer's 
disease and may accelerate disease progression through 
regulation of beta-site amyloid precursor protein-cleaving 
enzyme 1. J Neurosci. 2008 Jan 30;28(5):1213-23 
Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, 
Habbe N, Goggins MG, Mendell JT, Maitra A. Epigenetic 
silencing of MicroRNA miR-107 regulates cyclin-dependent 
kinase 6 expression in pancreatic cancer. Pancreatology. 
2009;9(3):293-301 
Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, 
Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, 
Kutsch N, Krause G, Mayr C, Rosenwald A, Plass C, 
Schultze JL, Hallek M, Wendtner CM. miRNA deregulation 
by epigenetic silencing disrupts suppression of the 
oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 
2009 Oct 8;114(15):3255-64 
Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub 
CO, Yasuda J. MiR-107 and MiR-185 can induce cell cycle 
arrest in human non small cell lung cancer cell lines. PLoS 
One. 2009 Aug 18;4(8):e6677 
Finnerty JR, Wang WX, Hébert SS, Wilfred BR, Mao G, 
Nelson PT. The miR-15/107 group of microRNA genes: 
evolutionary biology, cellular functions, and roles in human 
diseases. J Mol Biol. 2010 Sep 24;402(3):491-509 
Nelson PT, Wang WX. MiR-107 is reduced in Alzheimer's 
disease brain neocortex: validation study. J Alzheimers 
Dis. 2010;21(1):75-9 
Wang WX, Kyprianou N, Wang X, Nelson PT. 
Dysregulation of the mitogen granulin in human cancer 
through the miR-15/107 microRNA gene group. Cancer 
Res. 2010a Nov 15;70(22):9137-42 
Wang WX, Wilfred BR, Madathil SK, Tang G, Hu Y, 
Dimayuga J, Stromberg AJ, Huang Q, Saatman KE, 
Nelson PT. miR-107 regulates granulin/progranulin with 
implications for traumatic brain injury and 
neurodegenerative disease. Am J Pathol. 2010b 
Jul;177(1):334-45 
Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, 
Mendell JT, Huso D, Lowenstein CJ. P53-induced 
microRNA-107 inhibits HIF-1 and tumor angiogenesis. 
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9 
Yao J, Hennessey T, Flynt A, Lai E, Beal MF, Lin MT. 
MicroRNA-related cofilin abnormality in Alzheimer's 
disease. PLoS One. 2010 Dec 16;5(12):e15546 
Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, 
Lin MT, Chu CY, Hua KT, Chen CN, Kuo TC, Chang KJ, 
Hsiao M, Chang YW, Chen JS, Yang PC, Kuo ML. miR-
107 promotes tumor progression by targeting the let-7 
microRNA in mice and humans. J Clin Invest. 2011 
Sep;121(9):3442-55 
Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y, Wang X, 
Zhao Q, Ding J, Wu K, Fan D. MicroRNA-107, an 
oncogene microRNA that regulates tumour invasion and 
metastasis by targeting DICER1 in gastric cancer. J Cell 
Mol Med. 2011 Sep;15(9):1887-95 
Moncini S, Salvi A, Zuccotti P, Viero G, Quattrone A, 
Barlati S, De Petro G, Venturin M, Riva P. The role of miR-
103 and miR-107 in regulation of CDK5R1 expression and 
in cellular migration. PLoS One. 2011;6(5):e20038 
Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, 
Zavolan M, Heim MH, Stoffel M. MicroRNAs 103 and 107 
regulate insulin sensitivity. Nature. 2011 Jun 
8;474(7353):649-53 
Chen HY, Lin YM, Chung HC, Lang YD, Lin CJ, Huang J, 
Wang WC, Lin FM, Chen Z, Huang HD, Shyy JY, Liang JT, 
Chen RH. miR-103/107 promote metastasis of colorectal 
cancer by targeting the metastasis suppressors DAPK and 
KLF4. Cancer Res. 2012 Jul 15;72(14):3631-41 
Datta J, Smith A, Lang JC, Islam M, Dutt D, Teknos TN, 
Pan Q. microRNA-107 functions as a candidate tumor-
suppressor gene in head and neck squamous cell 
carcinoma by downregulation of protein kinase Cɛ. 
Oncogene. 2012 Sep 6;31(36):4045-53 
Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R. 
Clinicopathological and prognostic significance of 
microRNA-107 and its relationship to DICER1 mRNA 
expression in gastric cancer. Oncol Rep. 2012 
Jun;27(6):1759-64 
Piao L, Zhang M, Datta J, Xie X, Su T, Li H, Teknos TN, 
Pan Q. Lipid-based nanoparticle delivery of Pre-miR-107 
inhibits the tumorigenicity of head and neck squamous cell 
carcinoma. Mol Ther. 2012 Jun;20(6):1261-9 
Trivellin G, Butz H, Delhove J, Igreja S, Chahal HS, 
Zivkovic V, McKay T, Patócs A, Grossman AB, Korbonits 
M. MicroRNA miR-107 is overexpressed in pituitary 
adenomas and inhibits the expression of aryl hydrocarbon 
receptor-interacting protein in vitro. Am J Physiol 
Endocrinol Metab. 2012 Sep 15;303(6):E708-19 
Zhang SY, Surapureddi S, Coulter S, Ferguson SS, 
Goldstein JA. Human CYP2C8 is post-transcriptionally 
regulated by microRNAs 103 and 107 in human liver. Mol 
Pharmacol. 2012 Sep;82(3):529-40 
MIR107 (MicroRNA 107) Sharma P, Sharma R 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 18(8) 564 
Chen L, Chen XR, Zhang R, Li P, Liu Y, Yan K, Jiang XD. 
MicroRNA-107 inhibits glioma cell migration and invasion 
by modulating Notch2 expression. J Neurooncol. 2013a 
Mar;112(1):59-66 
Chen L, Zhang R, Li P, Liu Y, Qin K, Fa ZQ, Liu YJ, Ke 
YQ, Jiang XD. P53-induced microRNA-107 inhibits 
proliferation of glioma cells and down-regulates the 
expression of CDK6 and Notch-2. Neurosci Lett. 2013b 
Feb 8;534:327-32 
He J, Zhang W, Zhou Q, Zhao T, Song Y, Chai L, Li Y. 
Low-expression of microRNA-107 inhibits cell apoptosis in 
glioma by upregulation of SALL4. Int J Biochem Cell Biol. 
2013 Sep;45(9):1962-73 
Scarr E, Craig JM, Cairns MJ, Seo MS, et al.. Decreased 
cortical muscarinic M1 receptors in schizophrenia are 
associated with changes in gene promoter methylation, 
mRNA and gene targeting microRNA. Transl Psychiatry. 
2013 Feb 19;3:e230 
Sharma P, Saraya A, Gupta P, Sharma R. Decreased 
levels of circulating and tissue miR-107 in human 
esophageal cancer. Biomarkers. 2013 Jun;18(4):322-30 
This article should be referenced as such: 
Sharma P, Sharma R. MIR107 (MicroRNA 107). Atlas 
Genet Cytogenet Oncol Haematol. 2014; 18(8):559-564. 
